The utilization of left ventricular assist devices (LVADs) in end-stage heart failure has doubled in the past ten years and is bound to continue to increase. Since the first of these devices was approved in 1994, the technology has changed tremendously, and so has the medical and surgical management of these patients. In this review, we discuss the history of LVADs, evaluating survival and complications over time. We also aim to discuss practical aspects of the medical and surgical management of LVAD patients and future directions for outcome improvement in this population. Keywords: LVAD; heart failure; mechanical support
BACKGROUND: Because of the limited supply of donor hearts, prospective recipients continue to die wh...
In patients with end-stage heart failure, advanced therapies such as heart transplantation and long-...
Heart transplantation (HTx) improves symptoms and prolongs life in advanced heart failure (HF), but ...
PURPOSE OF REVIEW Use of durable left ventricular assist devices (LVADs) has increased considerab...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
AbstractThe increasing adoption of left ventricular assist devices (LVADs) into clinical practice is...
The increasing adoption of left ventricular assist devices (LVADs) into clinical practice is related...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...
The field of cardiac mechanical assist devices hasachieved a number of striking technical breakthrou...
During the last 20 years, the management of heart failure has significantly improved by means of new...
This thesis aims to assess the current body of evidence and experiences with continuous flow-LVADs i...
\(\bf Background/Aims:\) Long-term mechanical assist devices are now commonly used in the treatment ...
11 p.ill.,FOREWORD 1 -- SYNTHESIS 2 -- 1. ASSIST DEVICES FOR TREATMENT OF HEART FAILURE 3 -- 1.1. WH...
Mechanical circulatory support has emerged as an important option for patients with advanced heart f...
Durable left ventricular assist devices (LVADs) offer a viable option for patients with advanced hea...
BACKGROUND: Because of the limited supply of donor hearts, prospective recipients continue to die wh...
In patients with end-stage heart failure, advanced therapies such as heart transplantation and long-...
Heart transplantation (HTx) improves symptoms and prolongs life in advanced heart failure (HF), but ...
PURPOSE OF REVIEW Use of durable left ventricular assist devices (LVADs) has increased considerab...
Background: Heart transplantation remains the definitive therapy for patients with advanced heart fa...
AbstractThe increasing adoption of left ventricular assist devices (LVADs) into clinical practice is...
The increasing adoption of left ventricular assist devices (LVADs) into clinical practice is related...
Mechanical circulatory support is the most rapidly evolving strategy in heart failure management. Th...
The field of cardiac mechanical assist devices hasachieved a number of striking technical breakthrou...
During the last 20 years, the management of heart failure has significantly improved by means of new...
This thesis aims to assess the current body of evidence and experiences with continuous flow-LVADs i...
\(\bf Background/Aims:\) Long-term mechanical assist devices are now commonly used in the treatment ...
11 p.ill.,FOREWORD 1 -- SYNTHESIS 2 -- 1. ASSIST DEVICES FOR TREATMENT OF HEART FAILURE 3 -- 1.1. WH...
Mechanical circulatory support has emerged as an important option for patients with advanced heart f...
Durable left ventricular assist devices (LVADs) offer a viable option for patients with advanced hea...
BACKGROUND: Because of the limited supply of donor hearts, prospective recipients continue to die wh...
In patients with end-stage heart failure, advanced therapies such as heart transplantation and long-...
Heart transplantation (HTx) improves symptoms and prolongs life in advanced heart failure (HF), but ...